Takeda – Healthcare Data News

nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease

Collaboration aims to identify personalized treatment approaches and improve care for patients with IBD July 17, 2024 08:15 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference today announced a strategic research alliance...

April 11, 2023April 24, 2023 Collaborations Competitor News Pharma

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced...

July 4, 2022 AI Competitor News Fundraising/IPO

Takeda Canada Innovation Challenge Awarded to Pentavere to Accelerate Rare Disease Diagnosis and Care Using New AI Technology

FOR CANADIAN AUDIENCES ONLY Toronto-based Pentavere will collaborate with Takeda Canada and receive dedicated funding for new proof-of-concept AI project focused on Rare Disease care Innovation Challenge was launched to find new...

April 29, 2022 Collaborations Competitor News Data Partnership

CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally

April 28, 2022 06:30 ET | Source: Centogene NV Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing...